-
My Account
In App
My Account
BSE Live
Sep 05, 15:38Prev. Close
3.93
Open Price
3.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 10, 15:31Prev. Close
3.65
Open Price
3.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Ankur Drugs & Pharma (in Rs. Cr.) | Mar 12 | Mar 11 | Mar 10 | Mar 09 | Mar 08 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 158.98 | 35.58 | 44.56 | 19.94 | 49.41 | |
| Diluted EPS (Rs.) | 158.98 | 35.58 | 44.56 | 19.94 | 49.41 | |
| Cash EPS (Rs.) | -124.84 | -4.14 | 58.40 | 31.11 | 56.23 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -9.83 | 149.15 | 184.72 | 140.54 | 165.93 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -9.83 | 149.15 | 184.72 | 140.54 | 165.93 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 2.25 | 2.25 | 2.25 | |
| Revenue from Operations/Share (Rs.) | 78.32 | 426.46 | 552.00 | 518.79 | 530.46 | |
| PBDIT/Share (Rs.) | -14.33 | 69.71 | 116.05 | 71.34 | 84.75 | |
| PBIT/Share (Rs.) | -48.47 | 38.28 | 102.28 | 60.24 | 78.13 | |
| PBT/Share (Rs.) | -149.15 | -24.18 | 62.04 | 32.41 | 59.06 | |
| Net Profit/Share (Rs.) | -158.98 | -35.58 | 44.56 | 19.94 | 49.41 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -18.29 | 16.34 | 21.02 | 13.75 | 15.97 | |
| PBIT Margin (%) | -61.88 | 8.97 | 18.52 | 11.61 | 14.72 | |
| PBT Margin (%) | -190.42 | -5.66 | 11.23 | 6.24 | 11.13 | |
| Net Profit Margin (%) | -202.97 | -8.34 | 8.07 | 3.84 | 9.31 | |
| Return on Networth / Equity (%) | 1,616.68 | -23.85 | 24.12 | 14.19 | 29.77 | |
| Return on Capital Employed (%) | -33.80 | -8.35 | 9.92 | 4.92 | 9.29 | |
| Return on Assets (%) | -20.11 | -3.86 | 5.78 | 3.27 | 6.97 | |
| Total Debt/Equity (X) | -37.44 | 3.40 | 2.59 | 2.85 | 2.93 | |
| Asset Turnover Ratio (%) | 9.91 | 46.35 | 71.67 | 85.12 | 74.86 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.10 | 0.24 | 1.17 | 1.36 | 1.59 | |
| Quick Ratio (X) | 0.07 | 0.07 | 0.64 | 0.80 | 1.05 | |
| Inventory Turnover Ratio (X) | 8.57 | 4.99 | 3.29 | 4.54 | 5.47 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 5.04 | 11.52 | 6.67 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 3.85 | 7.38 | 5.86 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 94.96 | 88.48 | 93.33 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 96.15 | 92.62 | 94.14 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 94.95 | 88.47 | 93.32 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
